BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29017180)

  • 1. Targeting apoptosis in acute myeloid leukaemia.
    Cassier PA; Castets M; Belhabri A; Vey N
    Br J Cancer; 2017 Oct; 117(8):1089-1098. PubMed ID: 29017180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting apoptosis pathways for new cancer therapeutics.
    Bai L; Wang S
    Annu Rev Med; 2014; 65():139-55. PubMed ID: 24188661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superior anti-tumor activity of the MDM2 antagonist idasanutlin and the Bcl-2 inhibitor venetoclax in p53 wild-type acute myeloid leukemia models.
    Lehmann C; Friess T; Birzele F; Kiialainen A; Dangl M
    J Hematol Oncol; 2016 Jun; 9(1):50. PubMed ID: 27353420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis and Therapy of Acute Myeloid Leukemia].
    Medinger M; Heim D; Halter JP; Lengerke C; Passweg JR
    Ther Umsch; 2019; 76(9):481-486. PubMed ID: 32157963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis in leukemia: from molecular pathways to targeted therapies.
    Schimmer AD
    Best Pract Res Clin Haematol; 2008 Mar; 21(1):5-11. PubMed ID: 18342807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C; Hassan HT
    Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription of genes of p53-dependent apoptosis in acute leukaemia.
    Racay P; Hatok J; Hudecek J; Chudej J; Jurecekova J; Dobrota D
    Int J Mol Med; 2008 Dec; 22(6):833-9. PubMed ID: 19020783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low WT1 transcript levels at diagnosis predicted poor outcomes of acute myeloid leukemia patients with t(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantation.
    Qin YZ; Wang Y; Zhu HH; Gale RP; Zhang MJ; Jiang Q; Jiang H; Xu LP; Chen H; Zhang XH; Liu YR; Lai YY; Jiang B; Liu KY; Huang XJ
    Chin J Cancer; 2016 May; 35():46. PubMed ID: 27197573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel therapeutic strategies for AML in 2012.
    Tallman MS
    Hematology; 2012 Apr; 17 Suppl 1():S43-6. PubMed ID: 22507777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An expert overview of emerging therapies for acute myeloid leukemia: novel small molecules targeting apoptosis, p53, transcriptional regulation and metabolism.
    Saxena K; Konopleva M
    Expert Opin Investig Drugs; 2020 Sep; 29(9):973-988. PubMed ID: 32746655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel strategies to prevent relapse after allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia and myelodysplastic syndromes.
    Kekre N; Koreth J
    Curr Opin Hematol; 2015 Mar; 22(2):116-22. PubMed ID: 25575033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-apoptotic response to therapeutic DNA damage involves protein modulation of Mcl-1, Hdm2 and Flt3 in acute myeloid leukemia cells.
    Wergeland L; Sjøholt G; Haaland I; Hovland R; Bruserud Ø; Gjertsen BT
    Mol Cancer; 2007 May; 6():33. PubMed ID: 17498302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remission induction, consolidation and novel agents in development for adults with acute myeloid leukaemia.
    Hamadani M; Awan FT
    Hematol Oncol; 2010 Mar; 28(1):3-12. PubMed ID: 19645073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute myeloid leukemia.
    Rubnitz JE; Gibson B; Smith FO
    Hematol Oncol Clin North Am; 2010 Feb; 24(1):35-63. PubMed ID: 20113895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel approaches to the treatment of acute myeloid leukemia.
    Roboz GJ
    Hematology Am Soc Hematol Educ Program; 2011; 2011():43-50. PubMed ID: 22160011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. siRNA-mediated inhibition of antiapoptotic genes enhances chemotherapy efficacy in bladder cancer cells.
    Kunze D; Erdmann K; Froehner M; Wirth MP; Fuessel S
    Anticancer Res; 2012 Oct; 32(10):4313-8. PubMed ID: 23060552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-CD33-antibodies labelled with the alpha-emitter Bismuth-213 kill CD33-positive acute myeloid leukaemia cells specifically by activation of caspases and break radio- and chemoresistance by inhibition of the anti-apoptotic proteins X-linked inhibitor of apoptosis protein and B-cell lymphoma-extra large.
    Friesen C; Roscher M; Hormann I; Leib O; Marx S; Moreno J; Miltner E
    Eur J Cancer; 2013 Jul; 49(11):2542-54. PubMed ID: 23684782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase and murine double minute synergistically induces Apoptosis in acute myeloid leukemia via BH3-only proteins Puma and Bim.
    Zhang W; Konopleva M; Burks JK; Dywer KC; Schober WD; Yang JY; McQueen TJ; Hung MC; Andreeff M
    Cancer Res; 2010 Mar; 70(6):2424-34. PubMed ID: 20215498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecules involved in apoptosis regulation as therapeutic targets in oncology].
    Lheureux S; Le Moulec S
    Bull Cancer; 2011 Oct; 98(9):1029-36. PubMed ID: 21700547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted anti-leukemic therapy as disease-stabilizing treatment for acute myeloid leukemia relapse after allogeneic stem cell transplantation: Will it be possible to combine these strategies with retransplantation or donor lymphocyte infusions?
    Reikvam H; Kittang AO; Melve G; Mosevoll KA; Bentsen PT; Ersvær E; Gjertsen BT; Bruserud Ø
    Curr Cancer Drug Targets; 2013 Jan; 13(1):30-47. PubMed ID: 22873213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.